About this trial
The aim is to determine the prevalence of catheter-related thrombosis (CRT) in hospitalized patients carrying PICC, FICC, CICC, and midline catheters through a multicenter, standardized prevalence study. To achieve this, a cross-sectional study with prospective data collection will be conducted, including, through consecutive sampling to minimize selection bias, all hospitalized patients over 18 years of age from both general wards and critical care units who have had one of these catheters in place for at least 7 days. During data collection, an ultrasound examination of the catheter insertion site will be performed in order to rule out the presence of thrombotic complications.
Eligibility criteria
Qualifiers
All hospitalized patients aged ≥18 years from all hospital wards, including critical care units, who are carriers of a midline, FICC, PICC, or CICC catheter with a dwell time of at least 7 days will be included.
Disqualifiers
Patients who do not provide informed consent for the ultrasound assessment.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
Sponsors and collaborators
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Lead sponsor
Hospital del Mar Research Institute (IMIM)
Collaborator
Althaia Xarxa Assistencial Universitària de Manresa
Collaborator